SEC Filing Summary

Aaron G.L. Fletcher, a 10% owner and director of ACTUATE THERAPEUTICS, INC., acquired 15,000 Stock Options on May 21, 2026. These options have an exercise price of $2.42 and will vest in full on the anniversary of the grant date, May 21, 2026, expiring on May 21, 2036. The underlying security is Common Stock. The transaction was reported on Form 4 and is considered a direct ownership acquisition.